Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-009941·CG Oncology, Inc.
Schedule 13G ownership disclosure
CG oncology Inc
Common stock, $0.0001 par value per share · CUSIP: 156944100
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Unique Diamond Investments Limited
Shares: 586,982 · Class: 0.8%
- ORI Healthcare Fund, L.P.
Shares: 586,982 · Class: 0.8%
- ORI Capital Inc.
Shares: 586,982 · Class: 0.8%
- ORI Capital Holding Inc.
Shares: 586,982 · Class: 0.8%
- Charming Jade Limited
Shares: 3,003,931 · Class: 4%
- ORI Healthcare Fund II, L.P.
Shares: 3,003,931 · Class: 4%
- ORI Capital II Inc.
Shares: 3,003,931 · Class: 4%
- ORI Holding II Inc.
Shares: 3,003,931 · Class: 4%
- Healthcare Seed Limited
Shares: 3,590,913 · Class: 4.7%
- SONG, Hong Fang
Shares: 4,211,341 · Class: 5.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-009941
- Form type
- SCHEDULE 13G/A
- Filer
- CG Oncology, Inc.
- CIK
- CIK 1991792
- Filed
- Jan 28, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership